Genomics Startup Asa Ren Bags US$8.2 Mln Funding Round

By Editorial Team 14/02/2023
blood sample test
Summary

Indonesia-based genomic testing company Asa Ren has closed an early-stage but unnamed financing round worth nearly US$8.2 million. Top Harvest Capital, Kejora Capital, and Marcy Venture Partners co-led the round, with participation from Northstar Ventures, Naya Capital, PT Diagnos Laboratorium Utama, and several angel investors. 

Andy Zain, founder and managing partner of Kejora Capital, and Irawan Mulyadi, CEO of InterBio, have joined the board of Asa Ren As after the investment. Asa Ren currently offers direct-to-consumer DNA testing and related reports. The new funding will help it develop clinical bioinformatics technology, including an electronic health passport and clinicogenomics database for non-communicable diseases. 

"This [funding] provides a ripe opportunity for innovation and genetic research to improve the health and welfare of the country. We believe Asa Ren has all the right ingredients to capture this opportunity," Zain said in a statement, as quoted by genomeweb.com.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

Sign up
Log in
What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.